Arsenate reduction in human erythrocytes and rats - Testing the role of purine nucleoside phosphorylase

Toxicological Sciences

Volumn 74, Issue 1, 2003, Pages 22-31

  Németi, Balázs ^a   Csanaky, Iván ^a   Gregus, Zoltán ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Arsenate; Arsenite; Erythrocyte; Inosine; PNP inhibitor; Purine nucleoside phosphorylase; Reduction

Indexed keywords

ARSENIC ACID; ARSENIC TRIOXIDE; DITHIOTHREITOL; GUANOSINE; INOSINE; METHANEARSONIC ACID; OXIDOREDUCTASE; PURINE NUCLEOSIDE PHOSPHORYLASE; PURINE NUCLEOSIDE PHOSPHORYLASE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; BILE DUCT; BILIARY EXCRETION; BIOTRANSFORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE; ERYTHROCYTE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PROTEIN FUNCTION; RAT; SPECTROFLUOROMETRY; TOXICOKINETICS;

ANIMALS; ANTICARCINOGENIC AGENTS; BLOTTING, WESTERN; BODY WEIGHT; BONE DENSITY; CALCITRIOL; COLON; CYTOCHROME P-450 ENZYME SYSTEM; DIET; EATING; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; INDOLES; LIVER; MALE; MICROSOMES, LIVER; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; SEX CHARACTERISTICS; TESTOSTERONE;

ANIMALIA; MAMMALIA;

EID: 0037817843     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/kfg116     Document Type: Article

References (37)

1. Bzowska, A., Kulikowska, E., and Shugar, D. (2000). Purine nucleoside phosphorylase: Properties, functions, and clinical aspects. Pharmacol. Ther. 88, 349-425.
2. Csanaky, I., and Gregus, Z. (2001). Effect of phosphate transporter and methylation inhibitor drugs on the disposition of arsenate and arsenite in rats. Toxicol. Sci. 63, 29-36.
3. Csanaky, I., and Gregus, Z. (2002). Species variations in the biliary and urinary excretion of arsenate, arsenite and their metabolites. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 131, 355-365.
4. Csanaky, I., Németi, B., and Gregus, Z. (2003). Dose-dependent biotransformation of arsenite in rats - not S-adenosylmethionine depletion impairs arsenic methylation at high dose. Toxicology 183, 77-91.
5. Delnomdedieu, M., Basti, M. M., Styblo, M., Otvos, J. D., and Thomas, D. J. (1994). Complexation of arsenic species in rabbit erythrocytes. Chem. Res. Toxicol. 7, 621-627.
6. Dixon, H. B. F. (1997). The biochemical action of arsonic acids, especially as phosphate analogues. Adv. Inorg. Chem. 44, 191-227.
7. Fornaini, G., Magnani, M., Fazi, A., Accorsi, A., Stocchi, V., and Dachà, M. (1985). Regulatory properties of human erythrocyte hexokinase during cell ageing. Arch. Biochem. Biophys. 239, 352-358.
8. Fuhr, B. J., and Rabenstein, D. L. (1973). Nuclear magnetic resonance studies of the solution chemistry of metal complexes. IX. The binding of cadmium, zinc, lead, and mercury by glutathione. J. Amer. Chem. Soc. 95, 6944-6950.
9. Ginsburg, J. M., and Lotspeich, W. D. (1963). Interrelations of arsenate and phosphate transport in the dog kidney. Am. J. Physiol. 205, 707-714.
10. Goering, P. L., Aposhian, H. V., Mass, M. J., Cebrián, M., Beck, B. D., and Waalkes, M. P. (1999). The enigma of arsenic carcinogenesis: Role of metabolism. Toxicol. Sci. 49, 5-14.
11. Gomez-Ariza, J. L., Sánchez-Rodas, D., Beltran, R., Corns, W., and Stockwel, P. (1998). Evaluation of atomic fluorescence spectrometry as a sensitive detection technique for arsenic speciation. Appl. Organometal. Chem. 12, 439-447.
12. Gregus, Z., Gyurasics, Á., and Csanaky, I. (2000). Biliary and urinary excretion of inorganic arsenic: Monomethylarsonous acid as a major biliary metabolite in rats. Toxicol. Sci. 56, 18-25.
13. Gregus, Z., and Németi, B. (2002). Purine nucleoside phosphorylase as a cytosolic arsenate reductase. Toxicol. Sci. 70, 13-19.
14. Hindmarsh, J. T. (2000). Arsenic, its clinical and environmental significance. J. Trace Elem. Exp. Med. 13, 165-172.
15. Hoffee, P. A., May, R., and Robertson, B. D. (1978). Purine nucleoside phosphorylase from Salmonella typhimurium and rat liver. Meth. Enzymol. 51, 517-524.
16. Hughes, M. F. (2002). Arsenic toxicity and potential mechanisms of action. Toxicol. Lett. 133, 1-16.
17. 31P-nmr spectroscopy (in vivo and in vitro) with chemical and enzymic determinations of ATP, ADP, and P. Biochem. J. 229, 141-151.
18. Kala, S. V., Neely, M. W., Kala, G., Prater, C., Atwood, D. W., Rice, J. R., and Liebermann, W. (2000). The MRP2/cMOAT transporter and arsenic-glutathione complex formation are required for biliary excretion of arsenic. J. Biol. Chem. 275, 33404-33408.
19. Kalckar, H. M. (1947). Differential spectrophotometry of purine compounds by means of specific enzymes: I. Determination of hydroxypurines. J. Biol. Chem. 167, 429-443.
20. Kenney, L. J., and Kaplan, J. H. (1988). Arsenate substitutes for phosphate in the human red cell sodium pump and anion exchanger. J. Biol. Chem. 263, 7954-7960.
21. Knowles, F. C., and Benson, A. A. (1983). The biochemistry of arsenic. Trends Biochem. Sci. 8, 178-180.
22. McIntyre, L. M., Thorburn, D. R., Bubb, W. A., and Kuchel, P. W. (1989). Comparison of computer simulations of the F-type and L-type non-oxidative hexose monophosphate shunts with 31P-NMR experimental data from human erythrocytes. Eur. J. Biochem. 180, 399-420.
23. Németi, B., and Gregus, Z. (2002a). Mitochondria work as reactors in reducing arsenate to arsenite. Toxicol. Appl. Pharmacol. 182, 208-218.
24. Németi, B., and Gregus, Z. (2002b). Reduction of arsenate to arsenite in hepatic cytosol. Toxicol. Sci. 70, 4-12.
25. Parks, R. E., and Agarwal, R. P. (1972). Purine nucleoside phosphorylase. Enzymes 7, 483-514.
26. 50 in hamsters and in vitro inhibition of pyruvate dehydrogenase. Chem. Res. Toxicol. 14, 651-656.
27. Pillwein, K., Jayaram, H. N., and Weber, G. (1987). Effect of ischemia on nucleosides and bases in rat liver and hepatoma 3924A. Cancer Res. 47, 3092-3096.
28. Radabaugh, T. R., and Aposhian, H. V. (2000). Enzymatic reduction of arsenic compounds in mammalian systems: Reduction of arsenate to arsenite by human liver arsenate reductase. Chem. Res. Toxicol. 13, 26-30.
29. Radabaugh, T. R., Sampayo-Reyes, A., Zakharyan, R. A., and Aposhian, H. V. (2002). Arsenate reductase II. Purine nucleoside phosphorylase in the presence of dihydrolipoic acid is a route for reduction of arsenate to arsenite in mammalian systems. Chem. Res. Toxicol. 15, 692-698.
30. Stoeckler, J. D., Agarwal, R. P., Agarwal, K. C., and Parks, R. E. Jr. (1978). Purine nucleoside phosphorylase from human erythrocytes. Methods Enzymol. 51, 530-538.
31. Tavazzi, B., Di Pierro, D., Amorini, A. M., Fazzina, G., Tuttobene, M., Giardina, B., And Lazzarino, G. (2000). Energy metabolism and lipid peroxidation of human erythrocytes as a function of increased oxidative stress. Eur. J. Biochem. 267, 684-689.
32. Thomas, D. J., Styblo, M., and Lin, S. (2001). The cellular metabolism and systemic toxicity of arsenic. Toxicol. Appl. Pharmacol. 176, 127-144.
33. Vahter, M. (1983). Metabolism of arsenic. In Biological and Environmental Effects of Arsenic. (B. A. Fowler, Ed.), pp. 170-197. Elsevier Science, New York.
34. Wildenauer, D. B., Reuther, H., and Weger, N. (1982). Interactions of the chelating agent 2,3-dimercaptopropane-1-sulfonate with red blood cells in vitro. I. Evidence for carrier-mediated transport. Chem. Biol. Interact. 42, 165-177.
35. Winski, S. L., and Carter, D. E. (1995). Interactions of rat red blood cell sulfhydrils with arsenate and arsenite. J. Toxicol. Environ. Health 46, 379-397.
36. Zachara, B., Klem, J., and Kopff, M. (1981). Hypoxanthine nucleotides synthesis in fresh and stored human erythrocytes. Acta Biol. Med. Germ. 40, 683-689.
37. III ) is the substrate for MMA methyltransferase of rabbit liver and human hepatocytes. Toxicol. Appl. Pharmacol. 158, 9-15.